Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

AquaVita NextGen vs SkinnyRx

Two GLP-1 desks, one scoreboard. We put AquaVita NextGen and SkinnyRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 183 · Grade C

AquaVita NextGen

Visit AquaVita NextGen Full brief →
vs
No. 319 · Grade C

SkinnyRx

Visit SkinnyRx Full brief →

FDA warning letter, February 2026 — issued to Lean Rx, Inc. dba SkinnyRx. See the FDA's warning letter database.

The verdict

AquaVita NextGen takes this head-to-head.

AquaVita NextGen scores 67 to 58 on our six-factor Brief Score — AquaVita NextGen (AquaVita Wellness & Medspa) offers compounded semaglutide and tirzepatide (ODT tablets).

That doesn't make SkinnyRx a bad call — it's best for readers who will not inject and want a tablet at no premium over the injection, and who will check which term a "$199" is attached to before treating it as a monthly bill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
36
54
Supply Reliability
71
58
Transparency
88
62
Access Breadth
62
74
Clinical Oversight
82
55
Track Record
73
42
AquaVita NextGenBrief Score 67 · 58SkinnyRx

Price, coverage & the tracker

AquaVita NextGenSkinnyRx
Brief Score67/100 (C)58/100 (C)
SemaglutideFrom $375/mo (first-month rate, compounded)$349/mo month-to-month, compounded — the advertised $199 is the 12-month rung, billed as $2,388 in one payment
TirzepatideFrom $320/mo (starting dose, 3-month plan, compounded)$399/mo month-to-month, compounded, injection or tablet at the same price — the advertised $299 is the 12-month rung, billed as $3,588 in one payment
Coverage5 states47 states + Washington DC — not Alabama, Louisiana or Mississippi
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingNewnew to the tracker, no prior reading

AquaVita NextGen: New to the tracker on 1 August 2026. The published line reads From $320/mo (starting dose, 3-month plan, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

SkinnyRx: First reading, 8 August 2026. Month-to-month is $349 semaglutide and $399 tirzepatide, and the tirzepatide tablet costs exactly what the tirzepatide injection costs at all four terms. The "as low as $199 / $299" the site advertises are the twelve-month rungs, charged as $2,388 and $3,588 up front and auto-renewing annually. The separate microdose line costs the same as full dose at every shared term and floors higher, at $229 and $319, because it stops at eight months.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.